190 related articles for article (PubMed ID: 6613836)
1. Control of sudden recurrent arrhythmic deaths: role of amiodarone.
Nademanee K; Singh BN; Cannom DS; Weiss J; Feld G; Stevenson WG
Am Heart J; 1983 Oct; 106(4 Pt 2):895-901. PubMed ID: 6613836
[TBL] [Abstract][Full Text] [Related]
2. Clinical efficacy of amiodarone in treatment of recurrent ventricular tachycardia and ventricular fibrillation.
Heger JJ; Prystowsky EN; Zipes DP
Am Heart J; 1983 Oct; 106(4 Pt 2):887-94. PubMed ID: 6613835
[TBL] [Abstract][Full Text] [Related]
3. Long-term clinical outcome of ventricular tachycardia or fibrillation treated with amiodarone.
McGovern B; Garan H; Malacoff RF; DiMarco JP; Grant G; Sellers TD; Ruskin JN
Am J Cardiol; 1984 Jun; 53(11):1558-63. PubMed ID: 6731300
[TBL] [Abstract][Full Text] [Related]
4. Antiarrhythmic actions of amiodarone: a profile of a paradoxical agent.
Singh BN
Am J Cardiol; 1996 Aug; 78(4A):41-53. PubMed ID: 8780328
[TBL] [Abstract][Full Text] [Related]
5. Ventricular arrhythmias: use of electrophysiologic studies.
Horowitz LN; Spielman SR; Greenspan AM; Webb CR; Kay HR
Am Heart J; 1983 Oct; 106(4 Pt 2):881-6. PubMed ID: 6613834
[TBL] [Abstract][Full Text] [Related]
6. Amiodarone in refractory life-threatening ventricular arrhythmias.
Nademanee K; Singh BN; Hendrickson J; Intarachot V; Lopez B; Feld G; Cannom DS; Weiss JL
Ann Intern Med; 1983 May; 98(5 Pt 1):577-84. PubMed ID: 6846970
[TBL] [Abstract][Full Text] [Related]
7. Results of late programmed electrical stimulation and long-term electrophysiologic effects of amiodarone therapy in patients with refractory ventricular tachycardia.
Veltri EP; Reid PR; Platia EV; Griffith LS
Am J Cardiol; 1985 Feb; 55(4):375-9. PubMed ID: 3969872
[TBL] [Abstract][Full Text] [Related]
8. Disparity between the clinical and electrophysiologic effects of amiodarone in the treatment of recurrent ventricular tachyarrhythmias.
Hamer AW; Finerman WB; Peter T; Mandel WJ
Am Heart J; 1981 Dec; 102(6 Pt 1):992-1000. PubMed ID: 7315716
[TBL] [Abstract][Full Text] [Related]
9. Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic study.
Klein LS; Fineberg N; Heger JJ; Miles WM; Kammerling JM; Chang MS; Zipes DP; Prystowsky EN
Am J Cardiol; 1988 May; 61(13):1024-30. PubMed ID: 3364357
[TBL] [Abstract][Full Text] [Related]
10. Amiodarone in the management of patients with ventricular tachycardia and ventricular fibrillation.
Morady F; Scheinman MM; Hess DS
Pacing Clin Electrophysiol; 1983 May; 6(3 Pt 1):609-15. PubMed ID: 6191299
[TBL] [Abstract][Full Text] [Related]
11. Antiarrhythmic efficacy and electrophysiologic actions of amiodarone in patients with life-threatening ventricular arrhythmias: potent suppression of spontaneously occurring tachyarrhythmias versus inconsistent abolition of induced ventricular tachycardia.
Nademanee K; Hendrickson J; Kannan R; Singh BN
Am Heart J; 1982 Jun; 103(6):950-9. PubMed ID: 7081035
[No Abstract] [Full Text] [Related]
12. Amiodarone: clinical efficacy and toxicity in 96 patients with recurrent, drug-refractory arrhythmias.
Fogoros RN; Anderson KP; Winkle RA; Swerdlow CD; Mason JW
Circulation; 1983 Jul; 68(1):88-94. PubMed ID: 6851057
[TBL] [Abstract][Full Text] [Related]
13. Value of Holter monitoring in identifying risk for sustained ventricular arrhythmia recurrence on amiodarone.
Marchlinski FE; Buxton AE; Flores BT; Doherty JU; Waxman HL; Josephson ME
Am J Cardiol; 1985 Mar; 55(6):709-12. PubMed ID: 3976513
[TBL] [Abstract][Full Text] [Related]
14. Prospective clinical evaluation and follow-up of a cohort of consecutive VT/VF patients, using a staged-care protocol, including coronary arteriography, programmed electrical stimulation and cardiac surgery.
Naccarella F; Rolli A; Carboni A; Finardi A; Aurier E; Favaro L; Contini S; Gherli T; Caponi D; Maranga SS; Lepera G; Bartoletti A
G Ital Cardiol; 1999 Oct; 29(10):1142-56. PubMed ID: 10546124
[TBL] [Abstract][Full Text] [Related]
15. Five-year follow-up of 589 patients treated with amiodarone.
Weinberg BA; Miles WM; Klein LS; Bolander JE; Dusman RE; Stanton MS; Heger JJ; Langefeld C; Zipes DP
Am Heart J; 1993 Jan; 125(1):109-20. PubMed ID: 8417505
[TBL] [Abstract][Full Text] [Related]
16. [Anti-arrhythmic efficacy of the amiodarone-mexiletine combination in the treatment of resistant complex ventricular arrhythmias].
Purcaro A; Massacci C; Curzi G; Pigini G; Costantini C; Bilancini A; Blandini A
G Ital Cardiol; 1986 May; 16(5):417-26. PubMed ID: 3732727
[TBL] [Abstract][Full Text] [Related]
17. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators.
Cairns JA; Connolly SJ; Roberts R; Gent M
Lancet; 1997 Mar; 349(9053):675-82. PubMed ID: 9078198
[TBL] [Abstract][Full Text] [Related]
18. Electrophysiologic testing and follow-up of patients with aborted sudden death.
Eldar M; Sauve MJ; Scheinman MM
J Am Coll Cardiol; 1987 Aug; 10(2):291-8. PubMed ID: 3598002
[TBL] [Abstract][Full Text] [Related]
19. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of electrophysiologic testing in evaluation of amiodarone therapy for sustained ventricular tachyarrhythmias associated with coronary heart disease.
Horowitz LN; Greenspan AM; Spielman SR; Webb CR; Morganroth J; Rotmensch H; Sokoloff NM; Rae AP; Segal BL; Kay HR
Am J Cardiol; 1985 Feb; 55(4):367-71. PubMed ID: 3969870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]